Multicenter Cohort of Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia Receiving Daptomycin Plus Ceftaroline Compared With Other MRSA Treatments

Lignende værker

• Clinical Data on Daptomycin plus Ceftaroline versus Standard of Care Monotherapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
  af: Geriak, Matthew, et al.
  Udgivet: (2019)
• Reply to Kalil et al., “Is Daptomycin plus Ceftaroline Associated with Better Clinical Outcomes than Standard of Care Monotherapy for Staphylococcus aureus Bacteremia?”
  af: Sakoulas, George, et al.
  Udgivet: (2019)
• The combination of ceftaroline plus daptomycin allows for therapeutic de-escalation and daptomycin sparing against MRSA
  af: Barber, Katie E., et al.
  Udgivet: (2015)
• Observation of “Seesaw Effect” with Vancomycin, Teicoplanin, Daptomycin and Ceftaroline in 150 Unique MRSA Strains
  af: Barber, Katie E., et al.
  Udgivet: (2014)
• 1064. Clinical Outcomes of Daptomycin in Combination With Ceftaroline or Anti-Staphylococcal Penicillins for Patients With Persistent MRSA Bacteremia
  af: Bouchard, Jeannette, et al.
  Udgivet: (2018)